Literature DB >> 28055203

From Homology Models to a Set of Predictive Binding Pockets-a 5-HT1A Receptor Case Study.

Dawid Warszycki1, Manuel Rueda2, Stefan Mordalski1, Kurt Kristiansen3, Grzegorz Satała1, Krzysztof Rataj1, Zdzisław Chilmonczyk4, Ingebrigt Sylte3, Ruben Abagyan2, Andrzej J Bojarski1.   

Abstract

Despite its remarkable importance in the arena of drug design, serotonin 1A receptor (5-HT1A) has been elusive to the X-ray crystallography community. This lack of direct structural information not only hampers our knowledge regarding the binding modes of many popular ligands (including the endogenous neurotransmitter-serotonin), but also limits the search for more potent compounds. In this paper we shed new light on the 3D pharmacological properties of the 5-HT1A receptor by using a ligand-guided approach (ALiBERO) grounded in the Internal Coordinate Mechanics (ICM) docking platform. Starting from a homology template and set of known actives, the method introduces receptor flexibility via Normal Mode Analysis and Monte Carlo sampling, to generate a subset of pockets that display enriched discrimination of actives from inactives in retrospective docking. Here, we thoroughly investigated the repercussions of using different protein templates and the effect of compound selection on screening performance. Finally, the best resulting protein models were applied prospectively in a large virtual screening campaign, in which two new active compounds were identified that were chemically distinct from those described in the literature.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28055203      PMCID: PMC5361891          DOI: 10.1021/acs.jcim.6b00263

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  79 in total

1.  Analysis and comparison of 2D fingerprints: insights into database screening performance using eight fingerprint methods.

Authors:  Jianxin Duan; Steven L Dixon; Jeffrey F Lowrie; Woody Sherman
Journal:  J Mol Graph Model       Date:  2010-05-25       Impact factor: 2.518

Review 2.  Pharmacophore models for metabotropic 5-HT receptor ligands.

Authors:  Andrzej J Bojarski
Journal:  Curr Top Med Chem       Date:  2006       Impact factor: 3.295

3.  Stereoselectivity of 8-OH-DPAT toward the serotonin 5-HT1A receptor: biochemical and molecular modeling study.

Authors:  Joanna Dabrowska; Michal Brylinski
Journal:  Biochem Pharmacol       Date:  2006-05-16       Impact factor: 5.858

4.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

Authors:  Jonathan B Baell; Georgina A Holloway
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

5.  Conformational flexibility of serotonin1A receptor ligands from crystallographic data. Updated model of the receptor pharmacophore.

Authors:  Z Chilmonczyk; A Szelejewska-Wozniakowska; J Cybulski; M Cybulski; A E Koziol; M Gdaniec
Journal:  Arch Pharm (Weinheim)       Date:  1997-05       Impact factor: 3.751

6.  Structure based prediction of subtype-selectivity for adenosine receptor antagonists.

Authors:  Vsevolod Katritch; Irina Kufareva; Ruben Abagyan
Journal:  Neuropharmacology       Date:  2010-07-15       Impact factor: 5.250

7.  Structure-affinity relationship studies on 5-HT1A receptor ligands. 2. Heterobicyclic phenylpiperazines with N4-aralkyl substituents.

Authors:  B J van Steen; I van Wijngaarden; M T Tulp; W Soudijn
Journal:  J Med Chem       Date:  1994-08-19       Impact factor: 7.446

8.  ChEMBL: a large-scale bioactivity database for drug discovery.

Authors:  Anna Gaulton; Louisa J Bellis; A Patricia Bento; Jon Chambers; Mark Davies; Anne Hersey; Yvonne Light; Shaun McGlinchey; David Michalovich; Bissan Al-Lazikani; John P Overington
Journal:  Nucleic Acids Res       Date:  2011-09-23       Impact factor: 16.971

9.  Synthesis, docking studies and biological evaluation of benzo[b]thiophen-2-yl-3-(4-arylpiperazin-1-yl)-propan-1-one derivatives on 5-HT1A serotonin receptors.

Authors:  Hernán Pessoa-Mahana; Gonzalo Recabarren-Gajardo; Jenny Fiedler Temer; Gerald Zapata-Torres; C David Pessoa-Mahana; Claudio Saitz Barría; Ramiro Araya-Maturana
Journal:  Molecules       Date:  2012-02-03       Impact factor: 4.411

10.  A linear combination of pharmacophore hypotheses as a new tool in search of new active compounds--an application for 5-HT1A receptor ligands.

Authors:  Dawid Warszycki; Stefan Mordalski; Kurt Kristiansen; Rafał Kafel; Ingebrigt Sylte; Zdzisław Chilmonczyk; Andrzej J Bojarski
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

View more
  7 in total

1.  Influence of the Structural Accuracy of Homology Models on Their Applicability to Docking-Based Virtual Screening: The β2 Adrenergic Receptor as a Case Study.

Authors:  Stefano Costanzi; Austin Cohen; Abigail Danfora; Marjan Dolatmoradi
Journal:  J Chem Inf Model       Date:  2019-07-01       Impact factor: 4.956

2.  Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.

Authors:  Thomas Coudrat; John Simms; Arthur Christopoulos; Denise Wootten; Patrick M Sexton
Journal:  PLoS Comput Biol       Date:  2017-11-13       Impact factor: 4.475

Review 3.  Artificial intelligence and big data facilitated targeted drug discovery.

Authors:  Benquan Liu; Huiqin He; Hongyi Luo; Tingting Zhang; Jingwei Jiang
Journal:  Stroke Vasc Neurol       Date:  2019-11-07

Review 4.  G protein-coupled receptors: structure- and function-based drug discovery.

Authors:  Dehua Yang; Qingtong Zhou; Viktorija Labroska; Shanshan Qin; Sanaz Darbalaei; Yiran Wu; Elita Yuliantie; Linshan Xie; Houchao Tao; Jianjun Cheng; Qing Liu; Suwen Zhao; Wenqing Shui; Yi Jiang; Ming-Wei Wang
Journal:  Signal Transduct Target Ther       Date:  2021-01-08

5.  Ligand-biased ensemble receptor docking (LigBEnD): a hybrid ligand/receptor structure-based approach.

Authors:  Polo C-H Lam; Ruben Abagyan; Maxim Totrov
Journal:  J Comput Aided Mol Des       Date:  2017-09-08       Impact factor: 3.686

6.  Inhibition of the precursor and mature forms of HIV-1 protease as a tool for drug evaluation.

Authors:  Jana Humpolíčková; Jan Weber; Jana Starková; Eva Mašínová; Jana Günterová; Iva Flaisigová; Jan Konvalinka; Taťána Majerová
Journal:  Sci Rep       Date:  2018-07-11       Impact factor: 4.379

7.  Oncotoxic Properties of Serotonin Transporter Inhibitors and 5-HT1A Receptor Ligands.

Authors:  Jarosław Walory; Lidia Mielczarek; Małgorzata Jarończyk; Mirosława Koronkiewicz; Jerzy Kossakowski; Ryszard Bugno; Andrzej J Bojarski; Zdzisław Chilmonczyk
Journal:  Int J Mol Sci       Date:  2018-10-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.